Monocytes are circulating cells of the mononuclear phagocyte system that have been typically considered the precursors of tissue macrophages. It therefore came as a surprise that monocytes cultured with the cytokines interleukin-4 (IL-4) and granulocyte macrophage colony-stimulating factor (GM-CSF) become dendritic cells, the professional antigen-presenting cells that initiate T cell responses in lymphoid tissues (Sallusto and Lanzavecchia, 1994) . These monocyte-derived dendritic cells (Mo-DCs) capture soluble antigens with high efficiency and respond to microbial and inflammatory stimuli with coordinated changes that enhance their capacity for antigen presentation and T cell stimulation. However, after more than 15 years of study, the role of monocytes and Mo-DCs in induction of T cell responses in vivo remains unclear. In this issue, Steinman and colleagues (Cheong et al., 2010) show that in response to injection of lipopolysaccharide (LPS) or gram-negative bacteria, mouse monocytes migrate to peripheral lymph nodes. There they rapidly acquire the key properties of dendritic cells, such as a probing morphology and the capacity to present exogenous antigens to T cells that express the cell surface markers CD4 (CD4 + ) and CD8 (CD8 + ) (Cheong et al., 2010) . These data are compelling and the evidence suggests that Mo-DCs have a prominent role in initiating adaptive immunity to gram-negative bacteria.
Two types of resident dendritic cells with specialized functions are found in lymph nodes and spleen (Figure 1 ): dendritic cells that express CD8 and CD205 capture and present cell-associated antigens to CD8 + T cells in association with major histocompatibility complex (MHC) class I molecules, a mechanism known as crosspresentation, whereas dendritic cells that express CD11b, but not CD8 or DEC-205, capture and present soluble antigens to CD4 + T cells in association with MHC class II molecules. These two subsets develop under the influence of Flt3-L (Fms-like tyrosine kinase 3 ligand) from pre-dendritic cells, circulating precursors that have lost the capacity to differentiate along the monocyte/macrophage lineage (Liu and Nussenzweig, 2010) . Several studies using cell transfer experiments or reporter mice provide definitive evidence that in the steady state monocytes do not contribute significantly to the dendritic cell population of lymphoid organs (Jakubzick et al., 2008; Naik et al., 2006) .
To detect Mo-DCs, Cheong et al. used an antibody to mouse DC-SIGN, a lectin receptor expressed on human Mo-DCs generated in vitro but not on classical dendritic cells (Geijtenbeek et al., 2000) . The authors show that mouse DC-SIGN/ CD209 is expressed at low levels on fresh monocytes and upregulated upon culture with GM-CSF and IL-4, concomitant with loss of the monocyte markers Ly6C and c-fms/CD115. Using this antibody to stain tissue sections, the authors find very few DC-SIGN-positive cells in lymph nodes in the steady state. Strikingly, however, in mice challenged with LPS, large numbers of cells expressing DC-SIGN rapidly appear in the paracortical T cell areas of lymph nodes (Figure 1 ). Direct evidence that DC-SIGN-positive dendritic cells are derived from monocytes comes from experiments with mice that express the diphtheria toxin receptor in cells of the monocyte/macrophage lineage. When mice are treated with diphtheria toxin, DC-SIGN-positive cells fail to accumulate in lymph nodes following LPS challenge.
Using an ingenious in vivo labeling approach to isolate DC-SIGN-expressing cells from lymph nodes, the authors show that the newly recruited Mo-DCs efficiently present and cross-present to CD4 + and CD8 + T cells soluble and cellassociated antigens that have been taken up in vivo. These cells are even more potent than the two resident subsets of dendritic cells. Interestingly, Mo-DCs occupy a slightly different niche in the T cell area as compared to resident dendritic cells, suggesting that T cells may be differentially exposed to either cell type. Further studies using intravital microscopy combined with interventions to selectively deplete particular subsets of dendritic cells will be required to define the relative contributions of Mo-DCs to the induction of T cell proliferation and differentiation in vivo. The usefulness of antibodies to surface markers in these studies cannot be overemphasized, given the extensive heterogeneity and functional specialization of dendritic cells. In addition to DC-SIGN/ CD209, Cheong et al. show that two other markers can be used to identify mouse Mo-DCs in vivo: the mannose receptor (MMR/CD206), which is also upregulated in human Mo-DCs, and CD14, the LPS coreceptor, which is expressed on human and mouse monocytes. These reagents provide useful tools for future studies on the role of Mo-DCs in immune response.
How do monocytes and Mo-DCs reach lymph nodes? The conventional view is that monocytes first enter infected or inflamed nonlymphoid tissues where they capture antigen, mature, and subsequently migrate to the draining lymph nodes via the afferent lymph (Leon et al., 2007; Randolph et al., 1999) . In contrast, Cheong et al. report that monocytes migrate into lymph nodes in a manner dependent on the cell adhesion molecule CD62L and the chemokine receptor CCR7, consistent with a direct migration from blood through the high endothelial venules (Figure 1 ). The implication from these new findings is that depending on the nature of the microbe and its route of entry, monocytes can preferentially use one or the other pathway of migration and differentiation.
An intriguing finding of the study by Cheong et al. is that monocyte migration to lymph nodes and differentiation to antigen-presenting Mo-DCs could be elicited by administration of LPS or gramnegative bacteria, but not by administration of other Toll-like receptor (TLR) agonists or gram-positive bacteria. A possible explanation may lie in a marked upregulation of TLR4 and CD14 on mouse Mo-DCs, but it is worth asking whether this phenomenon is indeed limited to systemic challenge with gram-negative bacteria. Another intriguing finding is that Mo-DCs are found only in peripheral lymph nodes but not in spleen or mesenteric lymph nodes. Other studies have shown that monocytes can be recruited to the spleen by macrophages infected with Listeria monoytogenes (Serbina et al., 2003) . There the monocytes develop into inflammatory dendritic cells that mediate protection from infection through production of tumor necrosis factor (TNF) and inducible nitric oxide synthase (iNOS) but do not contribute to induction of T cell responses. It is possible that different gradients of chemokines and cytokines elicited in different tissues by microbial infection may determine the recruitment of monocytes and their differentiation into either inflammatory effector cells or antigen-presenting dendritic cells.
It will be interesting to determine whether and which cytokines trigger the rapid differentiation of dendritic cells from monocytes in the system used by Cheong et al. GM-CSF is capable of driving Mo-DC differentiation in vitro and together with M-CSF and Flt3-L has been shown to regulate the differentiation of monocytes, macrophages, and dendritic cells from bone marrow progenitors in vivo (Schmid et al., 2010) . A better understanding of the role of GM-CSF and other cytokines in the generation of MoDCs may provide new insights into their use as adjuvants for vaccination.
Dendritic cells are highly heterogeneous with respect to their capacity to respond to microbial and danger stimuli, to process and present self and non-self antigens, and to produce cytokines and costimulatory molecules that lead to different immune responses, from Th1-, Th2-, and Th17-mediated effector responses to suppression and tolerance. The new study by Cheong et al. provides conclusive evidence that monocytes belong to the extended dendritic cell family and introduces useful tools to study the role of Mo-DCs in these different types of immune responses. + and CD4 + T cells, respectively. Upon systemic challenge with lipopolysaccharide (LPS) or gram-negative bacteria, blood monocytes enter the lymph node through the high endothelial venules and rapidly differentiate to dendritic cells that efficiently present antigen to CD4 + and CD8 + T cells. These cells can be identified according to the expression of DC-SIGN, MMR (macrophage mannose receptor), and CD14. Monocyte-derived dendritic cells can also migrate to the lymph node from infected or inflamed tissues through the afferent lymph.
